PF-CBP1
A potent, highly selective CBP/p300 bromodomains inhibitor with IC50 of 125 nM and 363 nM, respectively; displays >100-fold selectivity for the bromodomain of CBP over those of BRD4 and a panel of other proteins; reduces the expression of inflammatory cytokines by LPS-stimulated primary macrophages, also suppresses the expression of RGS4 in primary cortical neurons.
Product Specifications
CAS Number
1962928-21-7
Product Name Alternative
PF CBP1
Field of Research
Cell Biology
Purity
>98% (HPLC)
Solubility
DMSO: 100 mg/mL (< 1 mg/ml refers to the product slightly soluble or insoluble)
Smiles
CCCOC1=CC=C (C=C1) CCC2=NC3=C (N2CCN4CCOCC4) C=CC (=C3) C5=C (ON=C5C) C
Molecular Formula
C29H36N4O3
Molecular Weight
488.6
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
4- (2- (5- (3,5-dimethylisoxazol-4-yl) -2- (4-propoxyphenethyl) -1H-benzo[d]imidazol-1-yl) ethyl) morpholine
Available Sizes
Explore Other Products
Browse additional items from our catalog
HN1L (Hematological and Neurological Expressed 1-like, C16orf34, FLJ13092, KIAA1426, L11) (APC)
HN1L (Hematological and Neurological Expressed 1-like, C16orf34, FLJ13092, KIAA1426, L11) (APC)
